Rami Al-Horani

Rami Al-Horani serves as Assistant Professor in the Division of Basic Pharmaceutical Sciences at Xavier University of Louisiana's College of Pharmacy since August 2016, focusing on drug discovery for cardiovascular and infectious diseases with emphasis on minority health disparities.

His educational trajectory includes:

• B.Pharm. from University of Jordan (2000)
• M.Sc. in Pharmaceutical Sciences from University of Jordan (2003)
• Ph.D. in Pharmaceutical Sciences from Virginia Commonwealth University (2007) funded by Fulbright predoctoral scholarship

Research centers on cardiovascular agents (antithrombotics/antifibrinolytics) and antimicrobials (antivirals), with pioneering work in heparin mimetics and coagulation factor inhibitors. His lab develops non-saccharide glycosaminoglycan analogs as safer anticoagulants targeting factors XIIa, XIa, and XIIIa.

Analysis of 15 recent publications (2024-2025) reveals dominant themes in heparin mimetics for cancer/viral applications, novel anticoagulants with reduced bleeding risk, and SARS-CoV-2 therapeutics. His work spans oncology, virology, and hematology with strong translational focus.

Major recognitions include:

• Fulbright predoctoral scholarship (2007)
• American Heart Association postdoctoral fellowship
• 2012 SOP VCU J. Doyle Smith award
• 2012 SOP VCU Dean's award
• 2016 VCU Donald and Nancy Abraham research award
• 2019 Louisiana Biomedical Research Network best faculty poster award

As active mentor and judge for the Annual Biomedical Research Conference for Minority Students, he secures NIH funding through Xavier's RCMI and Louisiana Biomedical Research Network. His service includes NSF panel participation and journal reviewing for AAPS and international publications. The research group maintains strong industry collaborations and patent portfolios in glycosaminoglycan mimetics.